Our Sponsors – GASL Jahrestagung

Our Sponsors 2024

We would like to thank our sponsors for their support in making
the 40th Annual Conference German Association for the Study of the Liver (GASL) a reality!

Your GASL organization team

Albireo AB

Ipsen Pharma GmbH, the national subsidiary of the Ipsen Group for Germany, Austria and Switzerland (DACH), is distributing transformative medicines in oncology, neuroscience and rare diseases, for which there is a high unmet medical need.

Homepage: https://www.ipsen.com/

6.000,00€

Amryt Pharma

Would you like to find out more about lipodystrophy?

Visit us at our booth number 6 or take a look at the online lipodystrophy diagnosis check on our website: www.de.lipodystrophy.eu

6.000,00€

AstraZeneca GmbH

We are leading a revolution in oncology to redefine cancer care. Our ambition is to follow the science to discover, develop and deliver life-changing treatments that transform outcomes and increase the potential for cure.

Homepage: https://www.astrazeneca.com/

6.000,00 €

Dr. Falk Pharma GmbH

Dr. Falk Pharma GmbH has been developing and marketing innovative medicines to treat a wide range of gastrointestinal disorders like inflammatory bowel disease or eosinophilic esophagitis as well as hepatobiliary disorders such as primary biliary cholangitis for over 60 years. The focus is on the development and distribution of innovative medicines that improve patients’ health and well-being. As the international experts in digestive and metabolic medicine, Dr. Falk Pharma has ten affiliates in Europe and Australia and is continuously growing. The family-owned business has its headquarters and R&D facilities in Freiburg, Germany, its pharmaceutical products are manufactured in Europe, mainly at sites in Germany, France, Italy and Switzerland.

Homepage: https://de.drfalkpharma.com/de/

6.000,00€

Ipsen Pharma GmbH

Homepage: https://www.ipsen.com/

6.000,00€

Johnson & Johnson Medical GmbH
– Ethicon

Ethicon, part of Johnson & Johnson MedTech, has made significant contributions to surgery for more than 100 years, from creating the first sutures, to revolutionizing surgery with minimally invasive procedures.

Homepage: https://www.jnjmedtech.com/en-EMEA/companies/ethicon

6.000,00€

Taiho Oncology Europe GmbH

The mission of Taiho Oncology Europe is to improve the lives of patients with cancer, their families, and their caregivers. The company specializes in orally administered anti-cancer agents and has a growing pipeline of selectively targeted anti-cancer agents. Taiho Oncology Europe GmbH (Zug, Switzerland) is the European subsidiary of Taiho Pharmaceutical Co., Ltd. (Tokyo, Japan).

For more information, visit www.taihooncology.eu

3.500,00€

Madrigal Pharmaceuticals

Madrigal is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need.

The company has advanced its lead investigational candidate into four Phase 3 clinical trials in NASH. Based on results reported to date, Madrigal submitted a new drug application to U.S. Food and Drug Administration seeking accelerated approval for the treatment of NASH with liver fibrosis.

NASH is a growing global health burden in all regions of the world, but many patients with NASH remain undiagnosed.

Homepage: https://www.madrigalpharma.com

3.000,00€

FUJIFILM Wako Chemicals Europe GmbH

FUJIFILM Wako Chemicals Europe GmbH ist ein Anbieter diagnostischer Reagenzien in Neuss. In der Hepatologie verfügt das Unternehmen über langjährige Erfahrung mit Serumassays für die Erkennung des Hepatozellulären Karzinoms sowie fortgeschrittener Leberfibrose.

Homepage: https://www.wako-chemicals.de/de/produkte/diagnostika/hcc-biomarker/

700,00€